Proactive Pharmacy Benefits Can Boost Profits
Skyrocketing pharmacy benefit costs, now 30-35% of employer healthcare spending, present a significant opportunity for private equity firms to create value. In a recent keynote interview with Buyouts Magazine, RxBenefits Private Equity Business Development Executive Will Statham details:
- How optimizing pharmacy benefits can directly boost portfolio company EBITDA.
- How client-aligned contracts and proactive clinical management can yield savings of 32% or more.
- Strategies to control rising expenses from high-cost specialty drugs and off-label use of GLP-1 medications like Ozempic.
- How standardizing pharmacy oversight and implementing data-driven controls can unlock immediate savings without compromising employee benefits.
Explore the full article in Buyouts Magazine for actionable steps to transform a major cost center into a powerful value creation lever for your portfolio companies.
